Venture Visionary Partners’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$6.64M Sell
35,770
-8,593
-19% -$1.6M 0.25% 99
2025
Q1
$9.3M Sell
44,363
-2,322
-5% -$487K 0.39% 66
2024
Q4
$8.3M Buy
46,685
+1,917
+4% +$341K 0.35% 73
2024
Q3
$8.84M Sell
44,768
-276
-0.6% -$54.5K 0.38% 74
2024
Q2
$7.73M Buy
45,044
+687
+2% +$118K 0.36% 77
2024
Q1
$8.08M Sell
44,357
-540
-1% -$98.3K 0.38% 72
2023
Q4
$6.96M Buy
44,897
+395
+0.9% +$61.2K 0.37% 77
2023
Q3
$6.63M Sell
44,502
-479
-1% -$71.4K 0.4% 69
2023
Q2
$6.06M Buy
44,981
+987
+2% +$133K 0.36% 77
2023
Q1
$7.01M Buy
43,994
+924
+2% +$147K 0.44% 62
2022
Q4
$6.96M Sell
43,070
-738
-2% -$119K 0.5% 50
2022
Q3
$5.88M Buy
43,808
+1,366
+3% +$183K 0.48% 53
2022
Q2
$6.5M Buy
42,442
+809
+2% +$124K 0.49% 49
2022
Q1
$6.75M Sell
41,633
-25,232
-38% -$4.09M 0.45% 58
2021
Q4
$9.09M Buy
66,865
+3,566
+6% +$485K 0.59% 43
2021
Q3
$6.85M Buy
63,299
+4,054
+7% +$438K 0.49% 50
2021
Q2
$6.68M Buy
59,245
+3,486
+6% +$393K 0.54% 40
2021
Q1
$6.03M Buy
55,759
+21,814
+64% +$2.36M 0.5% 44
2020
Q4
$3.64M Buy
33,945
+22,382
+194% +$2.4M 0.4% 54
2020
Q3
$1.05M Buy
11,563
+1,888
+20% +$171K 0.26% 59
2020
Q2
$949K Buy
9,675
+2,545
+36% +$250K 0.28% 53
2020
Q1
$543K Buy
7,130
+3,351
+89% +$255K 0.2% 74
2019
Q4
$334K Buy
+3,779
New +$334K 0.1% 121